La chaîne d'options affiche les données clés des options sur actions de ATRenew à différents prix d'exercice et dates d'expiration. Les traders utilisent ces informations pour analyser les transactions potentielles et évaluer le sentiment du marché pour ATRenew..

ATRenew (NYSE:RERE) Stock, Chaîne d'Options

ATRenew

ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.

AiHuiShou Intl

ATRenew Inc. American Depositary Shares (every three of which representing two Class A ordinary shares)

ATRenew Inc

Canaccord Genuity analyst Joseph Vafi maintains BILL Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BILL#NYSE">BILL</a>) with a Buy and lowers the price target from $105 to $75.

News

Price Target

Analyst Ratings

BILL

Canaccord Genuity Maintains Buy on BILL Holdings, Lowers Price Target to $75

Chardan Capital analyst Geulah Livshits maintains Lexeo Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LXEO#NASDAQ">LXEO</a>) with a Buy and lowers the price target from $22 to $20.

LXEO

Chardan Capital Maintains Buy on Lexeo Therapeutics, Lowers Price Target to $20

Needham analyst Joshua Reilly reiterates ZoomInfo Technologies Inc. - Common Stock (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GTM#NASDAQ">GTM</a>) with a Buy and maintains $15 price target.

Reiteration

Needham Reiterates Buy on ZoomInfo Technologies Inc. - Common Stock, Maintains $15 Price Target

WIIM

CYBR

CyberArk Software shares are trading lower. The company reported Q1 financial results.

The most oversold stocks in the information technology sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">CPI Card Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMTS#NASDAQ">PMTS</a>)</h3>
<ul class="wp-block-list">
<li>On May 7, CPI Card reported worse-than-expected first-quarter earnings. &#8220;We are pleased with our first quarter sales performance, led by strong growth from our debit and credit card portfolio,&#8221; said John Lowe, President and Chief Executive Officer. &#8220;Our outlook remains intact, and we plan to continue to execute our strategies to gain share and diversify our business, as evidenced by our acquisition of Arroweye Solutions.&#8221; The company's stock fell around 22% over the past five days and has a 52-week low of $18.46.</li>
<li>RSI Value: 29.4</li>
<li>PMTS Price Action: Shares of CPI Card fell 4.8% to close at $20.48 on Monday.</li>
<li>Edge Stock Ratings: 26.27 Momentum score with Value at 43.86. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://www.benzinga.com/quote/PMTS"><img loading="lazy" decoding="async" width="470" height="172" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13042818/image-134.png" alt="" class="wp-image-913102" style="width:372px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13042818/image-134.png 470w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13042818/image-134-300x110.png 300w" sizes="(max-width: 470px) 100vw, 470px" /></a></figure>
<h3 class="wp-block-heading">Astrotech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTC#NASDAQ">ASTC</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul class="wp-block-list">
<li>On Feb. 14, Astrotech reported its financial results for the second quarter of fiscal year 2025, which ended Dec. 31, 2024. Thomas B. Pickens, III, Astrotech&#8217;s Chairman, Chief Executive Officer and Chief Technology Officer, said &#8220;We are now prioritizing and accelerating our attention to selling and marketing our line of portable, rugged and inexpensive mass spectrometry instruments. We believe 1st Detect&#8217;s explosive trace detection products are now proven with four years of use in cargo warehouses having run thousands of samples at airports in 14 countries.&#8221; The company's stock fell around 16% over the past six months and <a href="https://www.benzinga.com/quote/ASTC">has a 52-week low</a> of $5.72.</li>
<li>RSI Value: 26.1</li>
<li>ASTC Price Action: Shares of Astrotech gained 2.3% to close at $5.90 on Monday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the trend in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0513">ASTC stock</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0513"><img loading="lazy" decoding="async" width="922" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13042933/image-135.png" alt="" class="wp-image-913105" style="width:523px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13042933/image-135.png 922w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13042933/image-135-300x274.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13042933/image-135-768x701.png 768w" sizes="(max-width: 922px) 100vw, 922px" /></a></figure>
<h3 class="wp-block-heading">reAlpha Tech Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AIRE#NASDAQ">AIRE</a>)</h3>
<ul class="wp-block-list">
<li>On April 28, reAlpha Tech announced the appointment of Cristol Rippe as Chief Marketing Officer. &#8220;Cristol&#8217;s arrival marks an exciting new chapter for the reAlpha executive team,&#8221; said Mike Logozzo, President and Chief Operating Officer of reAlpha. The company's stock fell around 16% over the past month and has a 52-week <a href="https://www.benzinga.com/quote/AIRE">low of $0.51.</a></li>
<li>RSI Value: 29.2</li>
<li>AIRE Price Action: Shares of reAlpha Tech fell 0.1% to close at $0.58 on Monday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential breakout in <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0513">AIRE shares</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href=" https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0513"><img loading="lazy" decoding="async" width="868" height="821" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13043038/image-136.png" alt="" class="wp-image-913108" style="width:616px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13043038/image-136.png 868w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13043038/image-136-300x284.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/13043038/image-136-768x726.png 768w" sizes="(max-width: 868px) 100vw, 868px" /></a></figure>
Learn more about BZ Edge Rankings—click to see scores for other stocks in the sector and s<a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">ee how they compare.</a> 
Read This Next:
<ul class="wp-block-list">
<li> <a href="https://www.benzinga.com/news/earnings/25/05/45368490/under-armour-cyberark-software-and-3-stocks-to-watch-heading-into-tuesday">Under Armour, CyberArk Software And 3 Stocks To Watch Heading Into Tuesday</a> </li>
</ul>
Photo via Shutterstock

Long Ideas

Pre-Market Outlook

Markets

Trading Ideas

AIRE

ASTC

PMTS

Top 3 Tech Stocks Which Could Rescue Your Portfolio This Quarter

Honda Motor shares are trading lower after the company reported a year-over-year decrease in FY25 GAAP EPS results.

ONON

On Holding shares are trading higher after the company reported better-than-expected Q1 financial results.

Immatics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMTX#NASDAQ">IMTX</a>) reported quarterly losses of $(0.35) per share which missed the analyst consensus estimate of $(0.33) by 6.06 percent. This is a 713.95 percent decrease over losses of $(0.04) per share from the same period last year. The company reported quarterly sales of $19.54 million which beat the analyst consensus estimate of $15.42 million by 26.73 percent. This is a 40.56 percent decrease over sales of $32.87 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

IMTX

Immatics Q1 EPS $(0.35) Misses $(0.33) Estimate, Sales $19.54M Beat $15.42M Estimate

WestPark Capital analyst Casey Ryan reiterates Innoviz Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INVZ#NASDAQ">INVZ</a>) with a Buy and maintains $2.22 price target.

INVZ

WestPark Capital Reiterates Buy on Innoviz Technologies, Maintains $2.22 Price Target

UnitedHealth Group shares are trading lower after the company announced it suspended its FY25 guidance. The company announced the appointment of Stephen Hemsley as CEO.

<ul>
<li>WonderFi will join Robinhood Crypto and continue to deliver crypto products to Canadian customers</li>
<li>WonderFi shareholders to receive all-cash consideration of C$0.36 per Common Share</li>
<li>Purchase price represents an attractive premium of approximately 41% to the closing price, and 71% to the 30-day VWAP, as of May 12</li>
</ul>

HOOD

Robinhood To Acquire WonderFi, A Canadian Crypto Platform, For C$250M In All-Cash Deal At C$0.36 Per Share

New BD FACSDiscover&#x2122; A8 Cell Analyzer Brings Leading-Edge Capabilities to Wider Range of Scientists across Academia and Biopharma
FRANKLIN LAKES, N.J., May 13, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BDX#NYSE">BDX</a>), a leading global medical technology company, announced the global commercial launch of the world's first cell analyzer featuring breakthrough spectral and real-time cell imaging technologies, enabling more researchers across a wider range of applications to uncover deeper insights and dynamics from cells once invisible in flow cytometry experiments – with increased ease and throughput.

BD Launches FACSDiscover A8 Cell Analyzer, Featuring Spectral And Real-Time Cell Imaging Technologies For Scientists In Academia And Biopharma

Needham analyst Charles Shi reiterates Cadence Design Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CDNS#NASDAQ">CDNS</a>) with a Buy and maintains $325 price target.

CDNS

Needham Reiterates Buy on Cadence Design Systems, Maintains $325 Price Target

COIN

Coinbase Global shares are trading higher it was announced that the company will join the S&P 500, effective before the opening of trading on Monday, May 19.

Sea shares are trading higher after the company reported better-than-expected Q1 EPS results.

On Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ONON#NYSE">ONON</a>) FY2025 Revenue expected to be at least CHF 2.86 billion.

Guidance

On Holding FY2025  Revenue expected to be at least CHF 2.86 billion.

Cellectar Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLRB#NASDAQ">CLRB</a>) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.16) by 12.5 percent. This is a 81.08 percent increase over losses of $(0.74) per share from the same period last year.

CLRB

Cellectar Biosciences Q1 EPS $(0.14) Beats $(0.16) Estimate, Cash $13.9M

Biotech

General

SKYE

Skye Bioscience Presented A Clinical Model On Peripheral CB1 Inhibition For Weight Loss At European Congress On Obesity

Rogers Sugar (TSX:<a class="ticker" href="https://www.benzinga.com/stock/RSI#TSX">RSI</a>) reported quarterly earnings of $0.13 per share which missed the analyst consensus estimate of $0.15 by 13.33 percent. This is a 23.53 percent decrease over earnings of $0.17 per share from the same period last year. The company reported quarterly sales of $326.31 million which beat the analyst consensus estimate of $323.43 million by 0.89 percent. This is a 8.43 percent increase over sales of $300.94 million the same period last year.

TSX:RSI

Rogers Sugar Q2 Adj. EPS $0.13 Misses $0.15 Estimate, Sales $326.31M Beat $323.43M Estimate

CODA

Coda Octopus Secures $1.5M US Navy Order For DAVD Tethered Systems With Echoscope, Highlighting Continued Investment in Subsea Tech

Press Releases

ATRenew to Report Third Quarter 2024 Financial Results on November 20, 2024

ATRenew Inc. Reports Unaudited Third Quarter 2024 Financial Results

ATRenew Inc. Included in UNGC's Forward Faster Campaign for Sustainable Development Contributions in China's Private Sector

Presenting on the Emerging Growth Conference 77 Day 1 on December 4th Register Now

Presenting on the Emerging Growth Conference 77 Day 2 on December 5th Register Now

ATRenew to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025

ATRenew Inc. Reports Unaudited Fourth Quarter and Full Year 2024 Financial Results

Comments

ATRenew

ATRenew (RERE) Options

No option chain data available. Please try again later

Notizie

PARTENAIRE / CONTRIBUTEUR

BENZINGA MONDIAL